JP2011510972A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011510972A5 JP2011510972A5 JP2010544816A JP2010544816A JP2011510972A5 JP 2011510972 A5 JP2011510972 A5 JP 2011510972A5 JP 2010544816 A JP2010544816 A JP 2010544816A JP 2010544816 A JP2010544816 A JP 2010544816A JP 2011510972 A5 JP2011510972 A5 JP 2011510972A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- oxo
- triaza
- hexahydro
- carboxylic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08290076.2 | 2008-01-29 | ||
| EP08290076A EP2090579A1 (en) | 2008-01-29 | 2008-01-29 | Substituted heteroarylamide diazepinopyrimidone derivatives |
| PCT/IB2009/000397 WO2009095792A2 (en) | 2008-01-29 | 2009-01-27 | Substituted heteroarylamide diazepinopyrimidone derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011510972A JP2011510972A (ja) | 2011-04-07 |
| JP2011510972A5 true JP2011510972A5 (https=) | 2012-01-19 |
| JP5611837B2 JP5611837B2 (ja) | 2014-10-22 |
Family
ID=39540691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010544816A Expired - Fee Related JP5611837B2 (ja) | 2008-01-29 | 2009-01-27 | 置換へテロアリールアミドジアゼピノピリミドン誘導体 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8507475B2 (https=) |
| EP (2) | EP2090579A1 (https=) |
| JP (1) | JP5611837B2 (https=) |
| KR (1) | KR20100117583A (https=) |
| CN (1) | CN101986782A (https=) |
| AR (1) | AR070273A1 (https=) |
| AU (1) | AU2009208731A1 (https=) |
| BR (1) | BRPI0906359A2 (https=) |
| CA (1) | CA2713289A1 (https=) |
| EA (1) | EA201070891A1 (https=) |
| IL (1) | IL207192A0 (https=) |
| MX (1) | MX2010008362A (https=) |
| NZ (1) | NZ587068A (https=) |
| TW (1) | TW200936588A (https=) |
| WO (1) | WO2009095792A2 (https=) |
| ZA (1) | ZA201005382B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2085399A1 (en) * | 2008-01-29 | 2009-08-05 | Sanofi-Aventis | substituted arylamide oxazepinopyrimidone derivatives |
| EP2085400A1 (en) * | 2008-01-29 | 2009-08-05 | Sanofi-Aventis | Substituted heteroarylamide oxazepinopyrimidone derivatives |
| EP2090578A1 (en) * | 2008-01-29 | 2009-08-19 | Sanofi-Aventis | Substituted arylamide diazepinopyrimidone derivatives for the treatment of neurodegenerative diseases caused by abnormal activity of GSK3-beta |
| EP2138494A1 (en) * | 2008-06-26 | 2009-12-30 | Sanofi-Aventis | Substituted alkyl pyrimidin-4-one derivatives |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| LT3416962T (lt) * | 2016-02-15 | 2021-07-12 | Sanofi | 6,7-dihidro-5h-benzo[7]anuleno dariniai kaip estrogenų recepptoriaus moduliatoriai |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EG13192A (en) | 1976-02-10 | 1982-12-31 | Rhone Poulenc Ind | Nouveaux derives du dithiole-1,2 leur preparation et les compositions qui les contiennent |
| US5629322A (en) | 1994-11-15 | 1997-05-13 | Merck & Co., Inc. | Cyclic amidine analogs as inhibitors of nitric oxide synthase |
| AU700078B2 (en) | 1995-11-01 | 1998-12-17 | Merck & Co., Inc. | Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| US20030096813A1 (en) | 2001-04-20 | 2003-05-22 | Jingrong Cao | Compositions useful as inhibitors of GSK-3 |
| CN1247586C (zh) | 2001-09-21 | 2006-03-29 | 赛诺菲安万特 | 治疗神经退化性疾病的取代的2－嘧啶基－6,7,8,9－四氢嘧啶并[1,2－a]嘧啶－4－酮及7－嘧啶基－2,3－二氢咪唑并[1,2－a]嘧啶－5(1h)酮衍生物 |
| EP1557417B1 (en) * | 2003-12-19 | 2007-03-07 | Sanofi-Aventis | Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-a] pyrimidin-6-one derivatives |
| EP1790649A1 (en) * | 2005-11-21 | 2007-05-30 | Sanofi-Aventis | Substituted bicyclic pyrimidone derivatives |
| EP2085399A1 (en) | 2008-01-29 | 2009-08-05 | Sanofi-Aventis | substituted arylamide oxazepinopyrimidone derivatives |
| EP2085400A1 (en) | 2008-01-29 | 2009-08-05 | Sanofi-Aventis | Substituted heteroarylamide oxazepinopyrimidone derivatives |
| EP2090578A1 (en) * | 2008-01-29 | 2009-08-19 | Sanofi-Aventis | Substituted arylamide diazepinopyrimidone derivatives for the treatment of neurodegenerative diseases caused by abnormal activity of GSK3-beta |
-
2008
- 2008-01-29 EP EP08290076A patent/EP2090579A1/en not_active Withdrawn
-
2009
- 2009-01-23 TW TW098103040A patent/TW200936588A/zh unknown
- 2009-01-27 AU AU2009208731A patent/AU2009208731A1/en not_active Abandoned
- 2009-01-27 CA CA2713289A patent/CA2713289A1/en not_active Abandoned
- 2009-01-27 BR BRPI0906359A patent/BRPI0906359A2/pt not_active IP Right Cessation
- 2009-01-27 EP EP09705869.7A patent/EP2238140B1/en active Active
- 2009-01-27 NZ NZ587068A patent/NZ587068A/en not_active IP Right Cessation
- 2009-01-27 KR KR1020107016905A patent/KR20100117583A/ko not_active Withdrawn
- 2009-01-27 CN CN2009801106975A patent/CN101986782A/zh active Pending
- 2009-01-27 JP JP2010544816A patent/JP5611837B2/ja not_active Expired - Fee Related
- 2009-01-27 EA EA201070891A patent/EA201070891A1/ru unknown
- 2009-01-27 WO PCT/IB2009/000397 patent/WO2009095792A2/en not_active Ceased
- 2009-01-27 MX MX2010008362A patent/MX2010008362A/es not_active Application Discontinuation
- 2009-01-28 AR ARP090100256A patent/AR070273A1/es unknown
-
2010
- 2010-07-25 IL IL207192A patent/IL207192A0/en unknown
- 2010-07-27 US US12/844,273 patent/US8507475B2/en not_active Expired - Fee Related
- 2010-07-28 ZA ZA2010/05382A patent/ZA201005382B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011510972A5 (https=) | ||
| AU2015222584B2 (en) | 2,4-disubstituted phenylene-1,5-diamine derivatives and applications thereof, and pharmaceutical compositions and pharmaceutically acceptable compositions prepared therefrom | |
| WO2020261114A1 (en) | 2,3-dihydroquinazolin compounds as nav1.8 inhibitors | |
| EP4277901A1 (en) | Isoindolinone compounds | |
| JP6951406B2 (ja) | フラバグリン誘導体 | |
| JP2016512823A5 (https=) | ||
| EP3189048A1 (en) | Aminoindane-, aminotetrahydronaphthalene- and aminobenzocyclobutane-derived prmt5-inhibitors | |
| JP6965478B2 (ja) | ２−アミノキナゾリノン誘導体 | |
| EA031614B1 (ru) | Трициклические атропоизомерные соединения | |
| Ma et al. | Discovery of novel quinoline-based mTOR inhibitors via introducing intra-molecular hydrogen bonding scaffold (iMHBS): The design, synthesis and biological evaluation | |
| JP2018536698A (ja) | Ｅｇｆｒキナーゼ阻害剤およびその製造方法と使用 | |
| JP2024001109A (ja) | Ｊａｋ阻害化合物のキシナホ酸塩 | |
| JP2016124825A (ja) | 多置換７−デアザプリン誘導体合成のための２，６−ジクロロ−８−ヨード−７−デアザプリン | |
| EP4051671A1 (en) | Fluorinated quinoline, quinoxaline and benzo[b][1,4]oxazine derivatives as dihydroorotate dehydrogenase (dhodh) inhibitors for the treatment of cancer, autoimmune and inflammatory diseases | |
| MX2009010243A (es) | Compuestos de quinolina apropiados para tratar trastornos que responden a la modulacion del receptor de serotonina 5-ht6. | |
| AU2009267828A1 (en) | Antineoplastic derivatives of 4-OXO-L, 4-dihydro-quinoline, preparation thereof, and therapeutic use thereof | |
| CN102249982B (zh) | 新型截短侧耳素类化合物、其药物组合物及其制备方法和用途 | |
| DK3189060T3 (en) | DERIVATIVES OF MACROCYCLIC N-ARYL-2-AMINO-4-ARYL-PYRIMIDINE POLYETHERS AS FTL3 AND JAK INHIBITORS | |
| US20120157482A1 (en) | Compounds and methods | |
| Xin et al. | Synthesis and pharmacological evaluation of trifluoromethyl containing 4-(2-pyrimidinylamino) benzamides as Hedgehog signaling pathway inhibitors | |
| JPWO2019059344A1 (ja) | 化学活性化型水溶性プロドラッグ | |
| KR20150117123A (ko) | 블로난세린의 온화한 제조방법 | |
| JP5017101B2 (ja) | 不斉四置換炭素原子含有化合物の製法 | |
| JP6935873B2 (ja) | ５−ｈｔ１ａ受容体によってコントロールされるセロトニン作動性制御に対する感受性が高い障害を処置するための新規化合物 | |
| JP5536771B2 (ja) | セロトニン作動性活性を有する化合物、その製造方法およびそれを含む医薬組成物 |